Cargando…

Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy

While the majority of thyroid cancer patients are easily treatable, those with anaplastic or poorly differentiated recurrent thyroid carcinomas have a very poor prognosis with a median survival of less than a year. Previously, we have shown a significant correlation between ICAM-1 overexpression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vedvyas, Yogindra, McCloskey, Jaclyn E., Yang, Yanping, Min, Irene M., Fahey, Thomas J., Zarnegar, Rasa, Hsu, Yen-Michael S., Hsu, Jing-Mei, Besien, Koen Van, Gaudet, Ian, Law, Ping, Kim, Nak Joon, Hofe, Eric von, Jin, Moonsoo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650612/ https://www.ncbi.nlm.nih.gov/pubmed/31337787 http://dx.doi.org/10.1038/s41598-019-46938-7

Ejemplares similares

Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2020)

SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
por: Alcaina, Yago, et al.
Publicado: (2022)

Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
por: Park, Spencer, et al.
Publicado: (2017)

Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
por: Jung, Minkyu, et al.
Publicado: (2020)

Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models
por: Yang, Yanping, et al.
Publicado: (2023)

Novel Strategy for Selection of Monoclonal Antibodies Against Highly Conserved Antigens: Phage Library Panning Against Ephrin-B2 Displayed on Yeast
por: Gu, Xiaoling, et al.
Publicado: (2012)

[(18)F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4
por: Amor-Coarasa, Alejandro, et al.
Publicado: (2019)

Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects
por: Deh, Kofi, et al.
Publicado: (2020)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma
por: Li, Fuxin, et al.
Publicado: (2020)

Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective
por: Finnerty, Brendan M, et al.
Publicado: (2017)

Global Manufacturing of CAR T Cell Therapy
por: Levine, Bruce L., et al.
Publicado: (2016)

Complex Structure of Engineered Modular Domains Defining Molecular Interaction between ICAM-1 and Integrin LFA-1
por: Kang, Sungkwon, et al.
Publicado: (2012)

Impact of Manufacturing Procedures on CAR T Cell Functionality
por: Watanabe, Norihiro, et al.
Publicado: (2022)

Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia
por: Sugita, Mayumi, et al.
Publicado: (2023)

Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses
Publicado: (1994)

Development of potent antibody drug conjugates against ICAM1(+) cancer cells in preclinical models of cholangiocarcinoma
por: Zhu, Bing, et al.
Publicado: (2023)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
por: Mhaidly, Rana, et al.
Publicado: (2020)

Distinct Subcellular Trafficking Resulting from Monomeric vs Multimeric Targeting to Endothelial ICAM-1: Implications for Drug Delivery
por: Ghaffarian, Rasa, et al.
Publicado: (2014)

Rapid manufacturing of non-activated potent CAR T cells
por: Ghassemi, Saba, et al.
Publicado: (2022)

Potential solutions for manufacture of CAR T cells in cancer immunotherapy
por: Blache, Ulrich, et al.
Publicado: (2022)

ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
por: Chong, Deborah L. W., et al.
Publicado: (2021)

Hot stamping advanced manufacturing technology of lightweight car body
por: Hu, Ping, et al.
Publicado: (2017)

Clinical manufacturing of CAR T cells: foundation of a promising therapy
por: Wang, Xiuyan, et al.
Publicado: (2016)

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
por: Zhang, Meng, et al.
Publicado: (2021)

Steering CAR T cell epigenetic programs by tweaking manufacturing protocol
por: Dukes, Meghan W., et al.
Publicado: (2023)

Characterization of Complex Concentrated Alloys and Their Potential in Car Brake Manufacturing
por: Anasiei, Ioana, et al.
Publicado: (2023)

Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
por: Si, Xiaohui, et al.
Publicado: (2022)

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
por: Li, Hongwen, et al.
Publicado: (2022)

The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis
por: Limberg, Jessica, et al.
Publicado: (2020)

OR08-06 Adjuvant Radiation Therapy Is Not Associated With A Survival Benefit After R0 Resection In Non-Metastatic Adrenocortical Carcinoma
por: Lee-Saxton, Yeon Joo, et al.
Publicado: (2023)

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development
por: Dickinson, Michael J., et al.
Publicado: (2023)

El periodismo industrial
por: McCloskey, James
Publicado: (1960)

IFN-γ surmounts PD-L1/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells
por: Dong, E, et al.
Publicado: (2021)

The role of ICAM-2 in neuroblastoma
por: Yoon, Karina J., et al.
Publicado: (2015)

Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3
Publicado: (1994)

Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium
por: Porter, Joanna C., et al.
Publicado: (2009)

ICAM‐1‐targeted nanocarriers attenuate endothelial release of soluble ICAM‐1, an inflammatory regulator
por: Manthe, Rachel L., et al.
Publicado: (2017)

Optimizing CAR-T Cell Manufacturing Processes during Pivotal Clinical Trials
por: Tyagarajan, Seshu, et al.
Publicado: (2019)

Large-scale manufacturing and characterization of CMV-CD19CAR T cells
por: Wang, Xiuli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdgop1k6d14f48rou8n6tdtr6a